Innoviva - 9 Year Dividend History | INVA

Historical dividend payout and yield for Innoviva (INVA) since 2016. The current TTM dividend payout for Innoviva (INVA) as of July 03, 2025 is $0.00. The current dividend yield for Innoviva as of July 03, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $1.206B $0.359B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $739.869B 56.73
Johnson & Johnson (JNJ) United States $375.371B 15.52
AbbVie (ABBV) United States $334.345B 18.43
Novo Nordisk (NVO) Denmark $308.844B 20.46
Roche Holding AG (RHHBY) Switzerland $257.924B 0.00
Novartis AG (NVS) Switzerland $257.504B 14.70
Merck (MRK) United States $203.218B 10.39
Pfizer (PFE) United States $144.295B 7.91
Sanofi (SNY) France $118.454B 11.67
Bayer (BAYRY) Germany $30.141B 6.14